Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus

Gastroenterology

Volumn 140, Issue 3, 2011, Pages 809-817

  Woreta, Tinsay A ^a   Sutcliffe, Catherine G ^b   Mehta, Shruti H ^b   Brown, Todd T ^a   Higgins, Yvonne ^a   Thomas, David L ^a,b   Torbenson, Michael S ^a   Moore, Richard D ^a,b   Sulkowski, Mark S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Cirrhosis; Liver Disease; Pathology

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

ADULT; ALCOHOL ABUSE; ALCOHOLIC FATTY LIVER; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DISEASE COURSE; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEGRO; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URBAN AREA;

EID: 79952284607     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.11.052     Document Type: Article

References (32)

1. M.S. Sulkowski, and D.L. Thomas Hepatitis C in the HIV-infected person Ann Intern Med 138 2003 197 207 (Pubitemid 36231625)
2. K.E. Sherman, S.D. Rouster, and R.T. Chung Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group Clin Infect Dis 34 2002 831 837 (Pubitemid 34194855)
3. M.S. Sulkowski, S.H. Mehta, and M.S. Torbenson Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults AIDS 21 2007 2209 2216 (Pubitemid 350287219)
4. E. Rosenthal, M. Poiree, and C. Pradier Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) AIDS 17 2003 1803 1809 (Pubitemid 37000098)
5. I. Bica, B. McGovern, and R. Dhar Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection Clin Infect Dis 32 2001 492 497 (Pubitemid 32173638)
6. F. Bani-Sadr, F. Carrat, and P. Bedossa Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors AIDS 20 2006 525 531 (Pubitemid 43731596)
7. L. Castra, M.A. Loko, and B. Le Bail Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype Aliment Pharmacol Ther 26 2007 1489 1498 (Pubitemid 350178805)
8. I. Gaslightwala, and E.J. Bini Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection J Hepatol 44 2006 1026 1032
9. K.M. Marks, L.M. Petrovic, and A.H. Talal Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus J Infect Dis 192 2005 1943 1949 (Pubitemid 41681892)
10. B.H. McGovern, J.S. Ditelberg, and L.E. Taylor Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infections in HIV-seropositive patients Clin Infect Dis 43 2006 365 372 (Pubitemid 44078910)
11. A. Monto, L.M. Dove, and A. Bostrom Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection Hepatology 42 2005 310 316 (Pubitemid 41061083)
12. D. Neau, M. Winnock, and L. Castra Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV J Acquir Immune Defic Syndr 45 2007 168 173
13. M. Rodrguez-Torres, S. Govindarajan, and R. Sol Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study J Hepatol 48 2008 756 764
14. R.K. Sterling, M.J. Contos, and P.G. Smith Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection Hepatology 47 2008 1118 1127 (Pubitemid 351547898)
15. M.S. Sulkowski, S.H. Mehta, and M. Torbenson Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus AIDS 19 2005 585 592 (Pubitemid 40543981)
16. K.Q. Hu, N.L. Kyulo, and E. Esrailian Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States J Hepatol 40 2004 147 154 (Pubitemid 38064724)
17. A. Monto, J. Alonzo, and J.J. Watson Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol Hepatology 36 2002 729 736 (Pubitemid 34977185)
18. L. Rubbia-Brandt, R. Quadri, and K. Abid Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 2000 106 115 (Pubitemid 30418941)
19. A. Carr, K. Samaras, and A. Thorisdottir A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51 F58
20. M.A. Noor, R.A. Parker, and E. O'Mara The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults AIDS 18 2004 2137 2144 (Pubitemid 39463678)
21. K. Brinkman, H.J.M. ter Hofstede, and D.M. Burger Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway AIDS 12 1998 1735 1744 (Pubitemid 28454438)
22. J.P. Van Huyen, A. Landau, and C. Piketty Toxic effects of nucleoside reverse transcriptase inhibitors on the liver: value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy Am J Clin Pathol 119 2003 546 555 (Pubitemid 37046406)
23. T.F. Babor, J.C. Higgins-Biddle, and J.B. Saunders AUDIT: The Alcohol Use Disorders Identification Test Guidelines for use in primary care 2nd ed. 2001 World Health Organization Geneva, Switzerland
24. E.M. Brunt, C.G. Janney, and A.M. Di Bisceglie Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474 (Pubitemid 29420675)
25. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C The METAVIR Cooperative Study Group Hepatology 24 1996 289 293 (Pubitemid 26260021)
26. A.Y. Kim, and R.T. Chung Coinfection with HIV-1 and HCVa one-two punch Gastroenterology 137 2009 795 814
27. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents December 1, 2009 Department of Health and Human Services 1 161 http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf Accessed March 1, 2010
28. P. Halfon, G. Penaranda, and F. Carrat Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients Aliment Pharmacol Ther 30 2009 61 70
29. J.E. Gallant, S. Staszewski, and A.L. Pozniak Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial JAMA 292 2004 191 201 (Pubitemid 38917996)
30. F.J. Torriani, M. Rodriguez-Torres, and J.K. Rockstroh Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450 (Pubitemid 38988593)
31. J.K. Keithley, A.M. Duloy, and B. Swanson HIV infection and obesity: a review of the evidence J Assoc Nurses AIDS Care 20 2009 260 274
32. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457 (Pubitemid 37466971)